Sudden death in congenital heart disease

Pediatric Clinics of North America

Volumn 51, Issue 5, 2004, Pages 1257-1271

  Pelech, Andrew N ^a   Neish, Steven R ^b  

^a Midwest Athletes Against Childhood Cancer Inc   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST;

AORTA DISEASE; AORTA DISSECTION; AORTA SUBVALVULAR STENOSIS; AORTA VALVE DISEASE; AORTA VALVE STENOSIS; CLINICAL FEATURE; CONGENITAL HEART DISEASE; EBSTEIN ANOMALY; ELECTROCARDIOGRAM; GREAT VESSELS TRANSPOSITION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MARFAN SYNDROME; PULMONARY ARTERY OCCLUSION; REVIEW; SUDDEN DEATH; TRANSLUMINAL VALVULOPLASTY;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; AORTIC STENOSIS, SUPRAVALVULAR; DEATH, SUDDEN, CARDIAC; EBSTEIN'S ANOMALY; EXERCISE TEST; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; PULMONARY VENO-OCCLUSIVE DISEASE; TETRALOGY OF FALLOT; VASCULAR RESISTANCE;

EID: 4344593443     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.04.013     Document Type: Review

References (83)

1. Zipes D.P., Wellens H.J. Sudden cardiac death. Clinical cardiology: new frontiers. Circulation. 98(21):1998;2334-2351
2. Myerburg R.J. Sudden cardiac death: epidemiology, causes, and mechanisms. Cardiology. 74(Suppl 2):1997;2-9
3. Mahle W.T., Spray T.L., Gaynor J.W., et al. Unexpected death after reconstructive surgery for hypoplastic left heart syndrome. Ann Thorac Surg. 71(1):2001;61-65
4. Kern J., Hayes C.J., Michler R.E., et al. Survival and risk factor analysis for the Norwood procedure for hypoplastic left heart syndrome. Am J Cardiol. 80(2):1997;170-174
5. Azakie T., Merklinger S.L., McCrindle B.W., et al. Evolving strategies and improving outcome of the modified Norwood procedure: a 10 year single institution experience. Ann Thorac Surg. 72(4):2001;1349-1353
6. Bartram U., Grunenfelder J., Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Ann Thorac Surg. 64(6):1997;1795-1802
7. Adams E.J., Chavez G.F., Steen D., et al. Changes in the epidemiologic profile of sudden infant death syndrome as rates decline among California infants: 1990-1995. Pediatrics. 102(6):1998;1445-1451
8. Hauck F.R., Hunt C.E. Sudden infant death syndrome in 2000. Curr Probl Pediatr. 30(8):2000;237-261
9. Harper R.M., Bandler R. Finding the failure mechanism in sudden infant death syndrome. Nat Med. 4(2):1998;157-158
10. Adelson L., Kinney E.R. Sudden and unexpected death in infancy and childhood. Pediatrics. 17:1956;663-699
11. Czegledy-Nagy E.N., Cutz E., Becker L.E. Sudden death in infants under one year of age. Pediatr Pathol. 13(5):1993;671-684
12. Dancea A., Cote A., Rohlicek C., et al. Cardiac pathology in sudden unexpected infant death. J Pediatrics. 141(3):2002;336-342
13. Oechslin E.N., Harrison D.A., Connely M.S., et al. Mode of death in adults with congenital heart disease. American Journal of Cardiology. 86:2000;1111-1116
14. Webb G.D., Williams R.G. Proceedings of the 32nd Bethesda Conference. Care of the adult with congenital heart disease. J Am Coll Cardiol. 37:2001;1161-1198
15. Liberthson R.R. Current concepts: sudden death from cardiac causes in children and young adults. N Engl J Med. 334(16):1996;1039-1044
16. Keith J.D. Prevalence, incidence, and epidemiology. Keith J.D., Rowe R.D., Vlad P. Heart disease in infancy and childhood. 3rd edition:1978;3-13 Macmillan Pub. Co. Inc., New York
17. Fyler D.C., Buckley L.P., Hellenbrand W.E., Cohn H.E. Report of the New England Regional Infant Program. Pediatrics. 65:1980;376-461
18. Mitchell S.C., Sellman A.H., Westphal M.C., et al. Etiologic correlates in a study of congenital heart disease in 56,109 births. Am J Cardiolo. 28:1971;653-657
19. Hoffman J.I.E., Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 42:1978;641-647
20. Ferencz C., Rubin J.D., Loffredo C.A., et al. Epidemiology of congenital heart disease: the Baltimore-Washington Infant Study, 1981-1989. Perspectives in pediatric cardiology. vol. 4:1993;Futura, Mount Kisco (NY)
21. Lambert E.C., Menon V.R., Wagner H.R., et al. Sudden unexpected death from cardiovascular disease in children. A cooperative international study. Am J Cardiol. 34:1974;89-96
22. Garson A. Jr., McNamara D.G. Sudden death in a pediatric cardiology population, 1958 to 1983: relation to prior arrhythmias. J Am Coll Cardiol. 5:1985;134B-137B
23. Granton J.T., Rabinovitch M. Pulmonary arterial hypertension and congenital heart disease. Card Clin. 20(3):2002
24. Steele T., Fuster V., Cohen M., et al. Isolated atrial septal defect with pulmonary vascular obstructive disease - long term follow up and prediction of outcome after surgical correction. Circulation. 76:1987;1037-1042
25. DiSesa V.J., Cohn L.H., Grossman W. Management of adults with congenital bidirectional cardiac shunts, cyanosis, and pulmonary vascular obstruction: successful operative repair in 3 patients. Am J Cardiol. 51(9):1983;1495-1497
26. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversal central shunt. BMJ. 46:1958;701-709
27. Baim D.S., Grossman W. Clinical measurement of vascular resistance and assessment of vasodilator drugs. Baim D.S., Grossman W. Cardiac catheterization, angiography, and intervention. 5th edition:1996;143-150 Williams and Wilkins, Baltimore (MD)
28. Eisenmenger V. Die angeborenen defects des kammerscheidewand des herzen. The innate defects of the chamber partition of the heart Z Klin Med. 31:1897;1-28
29. Rosenzweig E.B., Kerstein D., Barst R.J. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 99(14):1999;1858-1865
30. Barst R.J., Ivy D., Dingemanse J., et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther. 73(4):2003;372-382
31. Charpentier A., Levy F., Mettauer B., et al. Successful sequential double lung transplantation and cardiac repair for aortopulmonary window: technical and functional advantages over heart-lung transplantation. Transplant Proc. 28(5):1996;2878-2879
32. Mahle W.T., Spray T.L., Wernovsky G., et al. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation. 102(19 Suppl 3):2000;136-141
33. Canter C.E., Moorhead S., Huddleston C.B., et al. Cardio protection, cardiopulmonary bypass, electrophysiology: Restrictive atrial septal communication as a determinant of outcome of cardiac transplantation for hypoplastic left heart syndrome. Circulation. 88(5):1993;II456-II460
34. Barber G., Helton J.G., Agliar B.A., et al. The significance of tricuspid regurgitation in hypoplastic left heart syndrome. Am Heart J. 116:1988;1563-1567
35. Bartram U., Grunenfelder J., VanPraagh R. Causes of death after the modified Norwood procedure: a study of 122 post-mortem cases. Ann Thorac Surg. 64(6):1997;1795-1802
36. Bove E.L., Lloyd T.R. Staged reconstruction for hypoplastic left heart syndrome. Ann Surg. 224(3):1996;387-395
37. Ishino K., Stumper O., DeGiovanni J.J.V., et al. The modified Norwood procedure for hypoplastic left heart syndrome: early to intermediate results of 120 patients with particular reference to aortic arch repair. J Thorac Cardiovasc Surg. 117:1999;920-930
38. Gaynor J.W., Mahle W.T., Cohen M.I., et al. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg. 22(1):2002;82-89
39. McCrindle B.W., Blackstone E.H., Williams W.G., et al. Are outcomes of surgical versus transcatheter balloon valvotomy equivalent in neonatal critical aortic stenosis? Circulation. 104(12):2001;1152-1158
40. Lorell B.H., Carabello B.A. Left ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation. 102(4):2000;470-479
41. Recommendations for Determining Eligibility for Competition in Athletes with Cardiovascular Abnormalities. Bethesda Conference 26 (Revision of Bethesda Conference 16), January 6-7, 1994. J Am Coll Cardiol. 24:1994;845-899
42. Lund O. Preoperative risk evaluation and stratification of long term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention. Circulation. 82:1990;124-139
43. Lund O., Larsen K.E. Cardiac pathology after isolated valve replacement for aortic stenosis in relation to preoperative patient status: Early and late autopsy findings. Scand J Thorac Cardvasc Surg. 23:1989;263-270
44. Gerber I.L., Stewart R., Legget M.E., et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 107(14):2003;1884-1890
45. Bastianon V., Del Bolgia F., Boscioni M., et al. Altered cardiac repolarization during exercise in congenital aortic stenosis. Pediatr Cardiol. 14(1):1993;23-27
46. Pellikka P.A., Nishimura R.A., Bailey K.R., et al. The natural history of adults with asymptomatic hemodynamically significant aortic stenosis. J Amer Coll Card. 15:1990;1012-1017
47. Lund O., Nielsen T.T., Emmertsen K., et al. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg. 44:1996;289-295
48. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe asymptomatic aortic stenosis. N Engl J Med. 349(9):2000;611-617
49. Keane J.F., Driscoll D.J., Garsony W.M., et al. Second natural history of study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis. Circulation. 87(2):1993;I16-I27
50. Wolfe R.R., Driscol D.J., Gersony W.M., et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Circulation. 87:1993;89-101
51. Celermajer D.S., Cullen S., Sullivan I.D., et al. Outcome in neonates with Ebstein's anomaly. J Amer Coll Card. 19(5):1992;1041-1046
52. Tuzcu E.M., Moodi E.S., Ghazi A.F., et al. Ebstein's anomaly: natural and unnatural history. Cleve Clin J Med. 56(6):1989;614-618
53. Ross L., Thiene G. Mild Ebstein's anomaly associated with supraventricular tachycardia and sudden death: clinical morphologic features in three patients. Am J Card. 53:1984;332-334
54. Basso C., Corrado D., Rossi L., et al. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation. 103(2):2001;269-275
55. Teo W.S., Klein G.J., Yee R. Sudden cardiac death in the Wolf Parkinson White Syndrome. Singapore Med J. 33(3):1992;247-251
56. Huang C.J., Chiu I.S., Lin F.Y., et al. Role of electrophysiological studies in arrhythmia intervention in repairing Ebstein's anomaly. Thorac Cardvasc Surg. 46(6):2000;347-350
57. Liebman J., Cullum L., Belloc M.B. Natural history of transposition of the great arteries - anatomy and birth and death characteristics. Circulation. 40:1969;237-262
58. Williams H.G., Trusler G.A., Kirklin J.W., et al. Early and late results of the protocol for simple transposition leading to an atrial switch (mustard) repair. J Thorac Cardiovasc Surg. 95:1988;717-726
59. Puley G., Siu S., Connelly M., et al. Arrhythmia and survival in patients > 18 years of age after the mustard procedure for complete transposition of the great arteries. Am J Cardiol. 83:1999;1080-1084
60. Sarkar D., Bull C., Yates R., et al. Comparison of long-term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation. 100(9):1999;176-181
61. Jatene A.D., Fontes V.F., Paulista P.P., et al. Anatomic correction of transposition of the great vessels. J Thorac Cardiovasc Surg. 72(3):1976;364-370
62. Haas F., Wottke M., Poppert H., et al. Long-term survival and functional follow-up in patients after the arterial switch operation. Ann Thorac Surg. 68:1999;1692-1697
63. Losay J., Touchot A., Serraf A., et al. Late outcome after arterial switch operation for transposition of the great arteries. Circulation. 104(12):2001;I121-I126
64. Curran M.E., Atkinson D.L., Ewart A.K., et al. The elastin gene is disrupted by a translocation associated with supravalvar aortic stenosis. Cell. 73:1993;159-168
65. Ewart A.K., Morris C.A., Ensing G.J., et al. A human vascular disorder, supravalvar aortic stenosis, maps to 7. Proc Natl Acad Sci USA. 90:1993;3226-3230
66. Olson T.M., Michels V.V., Lindor N.M., et al. Autosomal dominant supravalvar aortic stenosis: localization to chromosome 7. Hum Mol Genet. 2:1993;869-873
67. Kececioglu D., Kotthoff S., Vogt J. Williams-Beuren syndrome: a 30 year follow-up of natural and postoperative course. Eur Heart J. 14:1993;1458-1464
68. Bird L., Billman G.S., Lacro R.V., et al. Sudden death in William's syndrome: report of 10 cases. J Pediatr. 129(6):1996;926-931
69. Milewicz D.M., Seidman C.E. Genetics of cardiovascular disease. Circulation. 102(20 Suppl 4):2000;103-111
70. Pepin M., Schwarze U., Superti-Furga A., et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 342:2000;673-680
71. Putnam E.A., Cho M., Zinn A.B., et al. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet. 12:1996;233-242
72. Sood S., Eldadah Z.A., Krause W.L., et al. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis syndrome. Nat Genet. 12:1996;209-211
73. Shores J., Berger K.R., Murphy E.A., et al. Progression of aortic dilation and the benefit of long-term β-blockade in Marfan's syndrome. N Engl J Med. 330:1994;1335-1341
74. Sehested J., Baandrup U., Mikkelsen E. Different reactivity and structure of the prestenotic and postenotic aorta in human coarctation. Implications for baroreceptor function. Circulation. 65:1982;1060
75. Fyler D.C. "Corrected" transposition of the great arteries. Fyler D.C. Nadas' pediatric cardiology. 3rd edition:1992;701-708 Mosby Yearbook, St. Louis (MO)
76. Freund M., Magener A., Schmidt K.G. Discordant atrial ventricular and ventricular arterial connections with partially unguarded left-sided atrial ventricular orifice and aortic atresia. Cardiol Young. 7:1997;45-453
77. Silka M.J., Hardy G.B., Menashe V.D., et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 32(1):1998;245-251
78. Murphy J.G., Gersh B.J., Mair D.D., et al. Long-term outcome in patients undergoing surgical repair of Tetralogy of Fallot. N Engl J Med. 18(2):1993;93-99
79. Chandar J.S., Wolff G.S., Garson A. Jr., et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol. 65:1990;655-661
80. Zahka K.G., Horneffer P.J., Rowe S.A., et al. Long-term valvar function after total repair of tetralogy of Fallot: relation to ventricular arrhythmias. Circulation. 78(Suppl 3):1988;14-19
81. Kavey R.E., Thomas F.D., Byrum C.J., et al. Ventricular arrhythmias and biventricular dysfunction after repair of tetralogy of Fallot. J Am Coll Cardiol. 4:1984;126-131
82. Vaksmann G., Fournier A., Davignon A., et al. Frequency and prognosis of arrhythmias after operative "correction" of tetralogy of Fallot. Am J Cardiol. 66:1990;346-349
83. Gatzoulis M.A., Till J.A., Somerville J., et al. Congestive heart disease: mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 92(2):1995;231-237